Three extra minutes on an MRI could catch a deadly side effect of cancer treatment

NCT ID NCT05125965

Ongoing Diagnosis Sponsor: Centre Chirurgical Marie Lannelongue Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study looks at whether adding just 3 minutes to a cardiac MRI can help doctors find heart inflammation (myocarditis) early in cancer patients on immunotherapy. Myocarditis is a rare but often deadly side effect of these drugs. The researchers will scan 200 patients who already need a heart MRI, to see if the extra time improves detection.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: additional time for the MRI
What this could lead to: If successful, this could make cardiac MRI a standard early test for heart inflammation caused by immunotherapy, improving survival.
What could go wrong: This is an observational study, not a treatment trial. The added MRI time may not improve detection enough to change outcomes.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for MYOCARDITIS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

myocarditis

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

MYOCARDITIS

Contacts and locations

Locations

Centre Chirurgical Marie Lannelongue

Le Plessis-Robinson, 92350, France
Hopital Paris Saint Joseph

Paris, 75014, France
Hôpital Europeen Marseille

Marseille, 13003, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.